Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 423421000001112 | Larotrectinib | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 423441000001119 | Larotrectinib (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Larotrectinib | Is a | Antineoplastic agent | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Larotrectinib 20mg/ml oral solution | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | False | Larotrectinib | Inferred relationship | Existential restriction modifier | |
| Larotrectinib sulfate | Is a | False | Larotrectinib | Inferred relationship | Existential restriction modifier | |
| Larotrectinib 20mg/ml oral solution 100 ml | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | False | Larotrectinib | Inferred relationship | Existential restriction modifier | |
| Vitrakvi 20mg/ml oral solution (Bayer Plc) 100 ml | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | False | Larotrectinib | Inferred relationship | Existential restriction modifier | |
| Vitrakvi 20mg/ml oral solution (Bayer Plc) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | False | Larotrectinib | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets